Navigation Links
Combination Drug Therapy For Hypertension

The conclusion drawn by the doctors after treating 65 million US citizens with hypertension is to initiate a combination therapy// to bring the blood pressure to normal range quickly, according to New York US (UPI).

A number of clinical studies since long has shown the advantage of giving multiple drugs and Paul Ridker, Professor of Medicine; Brigham and Women’s Hospital and Harward Medical School, Boston told United Press International that blood pressure can be brought to normal range better by using multiple drugs than using a single drug first and adding another drug later.

Keeping the blood pressure in the normal range decreases the risk of CVA, MI and nephropathy.

At the annual meeting of the American Society of Hypertension in New York, Ridker informed the importance of Valsartan (Diovan), an angiotensin receptor blocker in people with hypertension. Further a combination of Valsartan with a standard diuretic can bring the blood pressure further below.

Almost 50% of the patients on this combination therapy could achieve their blood pressure in the normal range compared to 32% on single drug, who could not get their levels to the desired range.

Joel Neutel, Medical director of the Orange County Heart Institute and Research Center, Orange, Calif. Reports from another study that combination of Amlodipine (Norvsc) and ACE inhibitor Quinapril (Accupril) / angiotensin receptor blocker losartan (Cozaar) helps in bringing the blood presuure to normal range than any of these drugs used single.

His study highlighted the importance of multiple drug therapy to monotherapy in diabetics with hypertension.

According to Neutel’s study, 27.5% of the difficult to treat hypertensive patients with blood pressure targets lower than those without diabetes could reach a target of 130/80 mm Hg compared to 12.5% on monotherapy.

Neutel in a press conference to UPI highlighted t he importance of combination therapy to reach the target blood pressure. In patients needing 3-4 drugs and he would prefer a diuretic as a third drug of choice.

In two other studies, doctors used the combination of two drugs, one to lower blood pressure and another to lower cholesterol. 50% 0f people with hypertension also have high blood cholesterol, another risk factor for the heart, according to John Kostis, Professor of medicine and pharmacology at the University of Medicine and Dentistry of New Jersey, New Brunswick.

Literature in TNT (Treating to New Targets) states that LDL cholesterol levels and blood pressure were low in people with lower cardiovascular problems (MI, CVA, need for relieving angina) said John Kostis.

He treated his patients with a combination of Norvasc and Lipitor (Atorvastatin).

In a study on African Americans, John Flack professor of medicine at Wayne State University, Detroit, used similar drugs. He used Caduet (combination of Norvasc and Lipitor) in people with mild / moderate / high hypertension.

48.3% patients could achieve normal blood pressure and normal cholesterol levels, 73.7 % could reach normal cholesterol levels and 56.8% could reach normal blood pressure levels on Cauduet.

Jan Basile, professor of medicine at the Medical University of South Carolina, Charleston stressed the need to review these studies and the commencement of combination therapy for the patients.

According to Flack, some doctors practice monotherapy and do not add/change the drug even in patients who continue to have high blood pressure.

He further stressed the need to get over physician / therapeutic inertia which is the biggest problem in cardiovascular management in tough to treat groups (diabetics and African Americans).


'"/>




Related medicine news :

1. Consensus on "Combination Therapy" for Breast Cancer
2. Drug Combinations May Boost Stroke Risk
3. Combination therapy to treat breast cancer
4. Combination regime may work against prostate cancer
5. Smoking and Breast Cancer - A Deadly Combination
6. New Drug Combination Found To Improve Memory in Alzheimer’s Patient
7. A Combination Of Drugs Effective In The Treatment Of Hormone-Refractory Prostate Cancer
8. Combination Therapy Effective In Improving Lung Cancer Survival
9. Combination Therapy Found To Improves Stroke Recovery
10. Combination Therapy Found To Be More Effective In Treating Brain Cancer
11. Combination of Clopidogrel-aspirin is better for preventing stroke than only aspirin
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/27/2017)... , ... February 27, 2017 , ... The threat of ... to work for a company involved in the underground testing of nuclear weapons. Years ... for Answers: Expendable Workers of the Cold War Nuclear Testing,” Clayton exposes the critical ...
(Date:2/27/2017)... ... 2017 , ... Orange County dentist, Dr. A. Rassouli, comments on ... when the bacteria in plaque infect the gums and other tissues supporting the teeth. ... planing or SRP, and can include surgical therapies if the condition has led to ...
(Date:2/27/2017)... ... February 26, 2017 , ... Miro is the ultimate smart media ... system brings songs, movies, TV shows and much more apps for user exploration. Its ... An immersive view of 1280 x 720 provides crisp images with remarkable clarity and ...
(Date:2/27/2017)... , ... February 27, 2017 , ... ... threshold mark last week. In addition, Discount Power's RCE (Residential Customer Equivalent) count ... in March 2014. The company had 800 customers and 2,250 RCEs at the ...
(Date:2/27/2017)... CA (PRWEB) , ... February 27, 2017 , ... ... for hair transplantation therapy, is proud to announce a new informational post on ... therapy procedures. Follicular Unit Extraction (FUE) hair transplant and Follicular Unit Transplantation (FUT) ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... Md. , Feb. 27, 2017  RegeneRx ... a clinical-stage drug development company focused on tissue ... licensee for RGN-137, GtreeBNT Co., Ltd., received a ... Phase 3 clinical trial design for RGN-137 to ... wound healing gel that incorporates Thymosin beta 4 ...
(Date:2/27/2017)... 27, 2017 A recent research report published ... market alone is expected to reach a value of $55.8 billion ... along with 28 states have legalized marijuana for medical uses. In ... Florida , North Dakota , ... to use the drug in medical applications such as chemotherapies and ...
(Date:2/27/2017)... N.J. and PETACH TIKVAH, Israel ... Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult ... appointments of June S. Almenoff , M.D., Ph.D., ... to its Board of Directors.  "Dr. ... executives whose appointments come at an exciting time for ...
Breaking Medicine Technology: